Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2015 3
2016 3
2017 2
2018 2
2019 3
2020 11
2021 20
2022 14
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean ren zhong[Author] (215 results)?
Evaluation of Clinical and Safety Outcomes of Neoadjuvant Immunotherapy Combined With Chemotherapy for Patients With Resectable Esophageal Cancer: A Systematic Review and Meta-analysis.
Ge F, Huo Z, Cai X, Hu Q, Chen W, Lin G, Zhong R, You Z, Wang R, Lu Y, Wang R, Huang Q, Zhang H, Song A, Li C, Wen Y, Jiang Y, Liang H, He J, Liang W, Liu J. Ge F, et al. Among authors: zhong r. JAMA Netw Open. 2022 Nov 1;5(11):e2239778. doi: 10.1001/jamanetworkopen.2022.39778. JAMA Netw Open. 2022. PMID: 36322089 Free PMC article.
Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung cancer: A systematic review and network meta-analysis.
Zhao Y, Cheng B, Chen Z, Li J, Liang H, Chen Y, Zhu F, Li C, Xu K, Xiong S, Lu W, Chen Z, Zhong R, Zhao S, Xie Z, Liu J, Liang W, He J. Zhao Y, et al. Among authors: zhong r. Crit Rev Oncol Hematol. 2021 Apr;160:103305. doi: 10.1016/j.critrevonc.2021.103305. Epub 2021 Mar 20. Crit Rev Oncol Hematol. 2021. PMID: 33757838 Review.
PD-L1 expression and Tumor mutation burden as Pathological response biomarkers of Neoadjuvant immunotherapy for Early-stage Non-small cell lung cancer: A systematic review and meta-analysis.
Deng H, Zhao Y, Cai X, Chen H, Cheng B, Zhong R, Li F, Xiong S, Li J, Liu J, He J, Liang W. Deng H, et al. Among authors: zhong r. Crit Rev Oncol Hematol. 2022 Feb;170:103582. doi: 10.1016/j.critrevonc.2022.103582. Epub 2022 Jan 11. Crit Rev Oncol Hematol. 2022. PMID: 35031441 Review.
Causal effects of genetically determined metabolites on cancers included lung, breast, ovarian cancer, and glioma: a Mendelian randomization study.
Feng Y, Wang R, Li C, Cai X, Huo Z, Liu Z, Ge F, Huang C, Lu Y, Zhong R, Li J, Cheng B, Liang H, Xiong S, Mao X, Chen Y, Lan R, Wen Y, Peng H, Jiang Y, Su Z, Wu X, He J, Liang W. Feng Y, et al. Among authors: zhong r. Transl Lung Cancer Res. 2022 Jul;11(7):1302-1314. doi: 10.21037/tlcr-22-34. Transl Lung Cancer Res. 2022. PMID: 35958335 Free PMC article.
Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study.
Deng H, Zhou J, Chen H, Cai X, Zhong R, Li F, Cheng B, Li C, Jia Q, Zhou C, Petersen RH, Rocco G, Brunelli A, Ng CSH, D'Amico TA, Su C, He J, Liang W, Zhu B; AME Thoracic Surgery Collaborative Group. Deng H, et al. Among authors: zhong r. Int J Surg. 2024 Jan 1;110(1):238-252. doi: 10.1097/JS9.0000000000000774. Int J Surg. 2024. PMID: 37755384 Free PMC article.
71 results